Skip to main content
MedPathMedPath Home
Clinical Trials/NCT02348229
NCT02348229
Completed
N/A

Effect of Enhanced Recovery After Surgery (ERAS) on C-reactive and Visceral Proteins in Patients With Advanced Gastric Cancer

The First Hospital of Jilin University0 sites149 target enrollmentSeptember 2013
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsGastric Cancer

Overview

Phase
N/A
Intervention
Not specified
Conditions
Gastric Cancer
Sponsor
The First Hospital of Jilin University
Enrollment
149
Primary Endpoint
Compartition of postoperative hospital stay
Status
Completed
Last Updated
11 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

The investigators designed a prospective randomized, controlled clinical trial then recruited 149 consecutive advanced gastric cancer patients. Further divided into a ERAS group (n=73) and a conventional pathway group (n=76). Surgical technique in both groups was same laparoscopic-assisted gastrectomy with D2 lymphadenectomy. Compared outcomes included clinical parameters and serum indicators.

Detailed Description

Enhanced recovery after surgery combined with laparoscopic-assisted gastrectomy was successfully carried out in this study. Recovery parameters such as the length of time to return to normal diet,mean hospital stay (d) were recorded.

Registry
clinicaltrials.gov
Start Date
September 2013
End Date
October 2014
Last Updated
11 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • •Age 18-75 years old
  • •Diagnosis confirmed by the endoscopic biopsy and total-body CT scan
  • •No history of the chronic renal disease ,chronic liver disease, cardiopulmonary dysfunction, ASA score≦3
  • •No neoadjuvant chemotherapy and radiotherapy
  • •No digestive obstruction and distant metastasis

Exclusion Criteria

  • •Conversion to open gastrectomy
  • •A large amount of bleeding leading(\>500ml)
  • •Patients withdrew their consent

Outcomes

Primary Outcomes

Compartition of postoperative hospital stay

Time Frame: up to 30 days after the operation

Secondary Outcomes

  • Change from baseline in C-Reactive Protein( CRP) and visceral proteins level(baseline and 5 days)

Similar Trials

Unknown
N/A
Enhanced Recovery After Surgery In Hirschsprung DiseaseHirschsprung Disease
NCT02776176Weibing Tang200
Unknown
N/A
The Effect of Advanced Improvement Program (ERAS) on Postoperative Outcomes in Patients Undergoing Open Heart SurgeryEnhanced Recovery After SurgeryOpen Heart Surgery
NCT03799965Kocaeli Derince Education and Research Hospital210
Completed
Phase 2
Enhanced Recovery After Surgery in Orthopaedic Spine SurgeryLumbar Surgery
NCT04562610University of California, Davis33
Completed
N/A
Enhanced Recovery for Patients Undergoing Radical Cystectomy.Post Procedural Discharge
NCT05210673Menoufia University50
Unknown
N/A
Prospective Randomized Controlled Trial of Impact of Enhanced Recovery After Surgery(ERAS) for Outcomes of Total Knee and Hip ArthroplastyArthroplasty, Replacement, Knee, Hip
NCT03869203Yonsei University100